Tag: Investing

Read More

EU initiative begins bid to open access to psychedelic therapies

A European citizens’ initiative aimed at promoting psychedelic-assisted treatments for mental health disorders has been registered by the European Commission. The initiative, dubbed “PsychedeliCare,” was registered on Sept. 11, according to the European Commission’s official website, in a bid to establish a transnational legal framework around psychedelic therapy in the …

Read More

Psyence inks several deals to expand psilocybin research, footprint

Psyence Biomedical Ltd (Nasdaq: PBM) is poised to hit several psilocybin-related “milestones” in coming months, including the acquisition of drug developer Clairvoyant, the launch of research into psilocybin as a treatment for substance use disorders and ongoing clinical trials in Australia for psilocybin in treating adjustment disorder. CEO Dr. Neil …